Leveraging AI to Support Strategic Go-To-Market Decisions
Know how AI can inform and accelerate go-to-market planning and outcomes
How can Artificial Intelligence (AI) drive pharma’s go-to-market strategy? The rise of complex specialty drugs, greater payer scrutiny, and the move towards value-based healthcare have made launching products challenging. Making effective commercial decisions depends on the interpretation of multiple data sources and AI can help shape go-to-market strategies in key areas such as customer segmentation, content creation and pricing. In this report experts explore the key AI technologies and strategies for unlocking product launch insights.
Companies
Roche, Daiichi Sankyo, Boehringer Ingelheim, IQVIA, Netflix, Aktana, ZS Associates, OpenAI, Adobe, Elsevier, Informa, Evaluate Pharma
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- Uncovering market trends
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Customer segmentation and targeting
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Tailoring and optimising content
- Issue summary
- Questions
- Key insights
- Supporting quotes
- KOL and thought leader mapping
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Pricing and reimbursement strategy
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- The future of AI-driven go-to-market decisions
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook